Investor Materials
The annual meeting of Reata Pharmaceuticals will be held on Wednesday, June 7, 2023, at 8:00 AM Central Time. The meeting will only be held virtually. Please register to be eligible to participate in the meeting.
You may request paper copies of the above materials, online, by email or by phone by dialing 866-648-8133.
Your vote is Important!
Please be sure to vote your shares online today or vote by phone by dialing 866-250-6195.
We are a biopharmaceutical company committed to developing and commercializing novel therapeutics for patients with serious or life-threatening diseases with few or no approved therapies. We focus on molecular pathways involved in the regulation of cellular metabolism and inflammation. For more information visit www.reatapharma.com.
Powered by Donnelley Financial Solutions
Copyright ©
Mediant Communications Inc.
All Rights Reserved.